Patient Charter 2026-2030
KEY DOCUMENT | FEBRUARY 2026
Lung cancer remains the leading cause of cancer death in Europe, yet people affected by lung cancer still face major differences in access to screening, diagnosis, treatment, information and support depending on where they live.
The Lung Cancer Europe Charter 2026–2030 sets out a shared set of expectations for lung cancer care across Europe.
It brings together 11 core commitments describing what people affected by lung cancer should be able to expect from health systems, policymakers and decision-makers. The Charter is intended to support advocacy, guide policy discussions and help reduce inequalities in lung cancer care.
Key Points
The Charter sets out 11 commitments for better lung cancer diagnosis, care, information and support.
It is grounded in lived experience and informed by Lung Cancer Europe’s work with member organisations, policymakers, researchers and healthcare professionals.
It focuses on more equitable, people-centred lung cancer care across Europe.
It is designed as a practical reference point for advocacy and policy discussions.
The Charter is not legally binding. It is a statement of shared expectations for health systems and decision-makers.